Sep 13, 2021 / 07:00PM GMT
Wing Cheung Yip - H.C. Wainwright & Co, LLC, Research Division - Research Analyst
Hello, everyone. This is Thomas Yip from H.C. Wainwright. For our next presentation, we have Mr. Peter Greenleaf. He is the CEO and Director of Aurinia Pharmaceuticals, a commercial stage company focused on delivering treatments for serious diseases with a high unmet need. Peter, very happy to have you with us at our conference. Please go ahead.
Peter S. Greenleaf - Aurinia Pharmaceuticals Inc. - President, CEO & Director
Thanks, Tom, and I want to thank everybody at H.C. Wainwright for having us at the conference today. Good afternoon to everyone who is joining us, and I hope the conference is going well for you.
I'm going to spend, I guess, about 20 minutes to walk you through who we are as a company. And if you're aware of who we are, to give you an update on the most recent events and what we've been up to as an organization. But before I do, let me point you to our forward-looking statements. And of course, all of our most recently filed filings with the SEC
Aurinia Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) - On-Demand Transcript
Sep 14, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers